| Data suggest that miR-107 is overexpressed in pituitary adenomas and acts as a tumor suppressor. | pituitary, |
| Data suggest that miR-107 is overexpressed in pituitary adenomas and acts as a tumor suppressor; pituitary tumor suppressor gene AIP (aryl hydrocarbon receptor-interacting protein) is a miR-107 target gene; both may have roles in tumorigenesis. | pituitary, |
| p53-induced miR-107 suppresses brain tumor cell growth and down-regulates CDK6 and Notch-2 expression, supporting its tumor suppressor role and utility as a target for glioma therapy. | brain,glioma, |
| MicroRNA-107 is downregulated and having tumor suppressive effect in breast cancer by negatively regulating brain-derived neurotrophic factor | breast,brain, |
| Results document that miR-107 functions as a tumor suppressor and inhibits the proliferation, migration and invasion of esophageal squamous cell carcinoma. | esophageal, |
| Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer | pancreatic, |
| Study provides evidence that miR-107 acts as a tumor suppressive RNA and regulates the proliferation of non-small cell lung cancer. Also, miR-107 targets IKBKG, a critical regulator of NF-kB activation. | lung, |
| MiR-107 function as a tumor suppressor gene in colorectal cancer by targeting transferrin receptor 1 | colorectal, |
| MicroRNA-107 is a novel tumor suppressor targeting POU3F2 in melanoma | skin, |
| Data demonstrate that miR-107 negatively regulates the tumor suppressor miRNA let-7 via a direct interaction. | None |
| miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. | leukemia, |
| miR-107, an oncogene miRNA promoting gastric cancer metastasis through down-regulation of DICER1. | gastric, |
| MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer. | gastric, |